Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 4 Grant or award Chief Medical Officer acquired 19,132 shares (grant or award)
  2. 4 Grant or award See remarks acquired 51,020 shares (grant or award)
  3. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 38,265 shares (grant or award)
  4. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 51,021 shares (grant or award)
  5. 4 Grant or award Director acquired 255,102 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 218,600 shares at an average $4.03 ($882,028)
  8. 4 Open-market sale See remarks sold 118,849 shares at an average $3.60 ($427,860)
  9. 4 Open-market sale See remarks sold 56,596 shares at an average $3.55 ($201,124)
  10. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 14,500 shares at $3.38 ($49,010)
  11. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 260,427 shares at an average $3.45 ($899,538)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Option exercise See remarks acquired 366,532 shares (option exercise)
  15. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 473,902 shares (option exercise)
  16. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 26,858 shares at $3.48 ($93,466)
  17. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,100 shares at $3.31 ($16,879)
  18. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,594 shares at $3.31 ($8,585)
  19. 4 Open-market sale See remarks sold 1,834 shares at $3.31 ($6,070)
  20. 4 Derivatives Options or other derivatives

Page 2 of 14 · 263 filings